Screener
First Tracks Biotherapeutics Inc TRAX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Where this comes from
Reported directly by First Tracks Biotherapeutics Inc in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: First Tracks Biotherapeutics Inc’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224190
| Line item | March 31, 2026 | December 31,2025 |
|---|---|---|
| Current portion of operating lease liability | — | 2,080 |
| Total current liabilities | 33,112 | 31,023 |
| Operating lease liability, net of current portion | — | 12,032 |
| Equity: | ||
| Net Parent Investment | 257,610 | 287,514 |
| Accumulated other comprehensive loss | (146) | (24) |
| Total equity | 257,464 | 287,490 |
| Total liabilities and equity | $290,576 | $330,545 |
Item 1. Combined Financial Statements.
FAQ
- What is First Tracks Biotherapeutics Inc's total liabilities & equity?
- First Tracks Biotherapeutics Inc (TRAX) reported total liabilities & equity of $290.58M in Q1 2026.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about First Tracks Biotherapeutics Inc's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude